Search Results - "Vrignaud, P"

Refine Results
  1. 1

    Predictors of depression in multiple sclerosis patients by Gay, M-C., Vrignaud, P., Garitte, C., Meunier, C.

    Published in Acta neurologica Scandinavica (01-03-2010)
    “…Gay M‐C, Vrignaud P, Garitte C, Meunier C. Predictors of depression in multiple sclerosis patients.
Acta Neurol Scand: 2010: 121: 161–170.
© 2010 The Authors…”
    Get full text
    Journal Article
  2. 2

    Can taxanes provide benefit in patients with CNS tumors and in pediatric patients with tumors? An update on the preclinical development of cabazitaxel by Sémiond, D., Sidhu, S. S., Bissery, M.-C., Vrignaud, P.

    Published in Cancer chemotherapy and pharmacology (01-09-2013)
    “…Purpose While first-generation taxanes are valuable treatment options for many solid tumors, they are limited by an inability to cross the blood–brain barrier…”
    Get full text
    Journal Article
  3. 3

    Changes in effective connectivity during incidental and intentional perception of fearful faces by de Marco, G., de Bonis, M., Vrignaud, P., Henry-Feugeas, M.C., Peretti, I.

    Published in NeuroImage (Orlando, Fla.) (15-04-2006)
    “…The present fMRI study examined effective connectivity within an emotional network composed of three brain areas: Amygdala (AMY), Anterior Cingulate Cortex…”
    Get full text
    Journal Article
  4. 4

    Differences in effective connectivity between dyslexic children and normal readers during a pseudoword reading task: An fMRI study by Quaglino, V, Bourdin, B, Czternasty, G, Vrignaud, P, Fall, S, Meyer, M.E, Berquin, P, Devauchelle, B, de Marco, G

    Published in Neurophysiologie clinique (01-04-2008)
    “…Summary Purpose This fMRI study investigated phonological and lexicosemantic processing in dyslexic and in chronological age- and reading level-matched…”
    Get full text
    Journal Article
  5. 5

    Preclinical evaluation of docetaxel (Taxotere) by Lavelle, F, Bissery, M C, Combeau, C, Riou, J F, Vrignaud, P, André, S

    Published in Seminars in oncology (01-04-1995)
    “…Progress in cancer chemotherapy has been made owing to the discovery and development of drugs that have new structures, new mechanisms of action, and high…”
    Get more information
    Journal Article
  6. 6

    Circadian optimisation of irinotecan and oxaliplatin efficacy in mice with Glasgow osteosarcoma by GRANDA, T. G, D'ATTINO, R.-M, FILIPSKI, E, VRIGNAUD, P, GARUFI, C, TERZOLI, E, BISSERY, M.-C, LEVI, F

    Published in British journal of cancer (18-03-2002)
    “…The relevance of circadian rhythms in irinotecan and oxaliplatin tolerability was investigated with regard to antitumour activity. Mice bearing Glasgow…”
    Get full text
    Journal Article
  7. 7

    Experimental chronotherapy of mouse mammary adenocarcinoma MA13/C with docetaxel and doxorubicin as single agents and in combination by GRANDA, T. G, FILIPSKI, E, D'ATTINO, R. M, VRIGNAUD, P, ANJO, A, BISSERY, M. C, LEVI, F

    Published in Cancer research (Chicago, Ill.) (01-03-2001)
    “…The therapeutic index of docetaxel, doxorubicin and their combination may be improved by an adequate selection of the circadian time of administration. The…”
    Get full text
    Journal Article
  8. 8

    Experimental antitumor activity and pharmacokinetics of the camptothecin analog irinotecan (CPT-11) in mice by Bissery, M C, Vrignaud, P, Lavelle, F, Chabot, G G

    Published in Anti-cancer drugs (01-06-1996)
    “…Irinotecan (CPT-11) is a semi-synthetic derivative of camptothecin currently in clinical trials. In vitro, CPT-11 presented preferential cytotoxicity toward…”
    Get more information
    Journal Article
  9. 9

    Preclinical profile of docetaxel (taxotere): efficacy as a single agent and in combination by Bissery, M C, Vrignaud, P, Lavelle, F

    Published in Seminars in oncology (01-12-1995)
    “…Docetaxel (Taxotere; Rhône-Poulenc Rorer, Antony, France) is a new taxoid currently being studied in phase II and III clinical trials worldwide, with promising…”
    Get more information
    Journal Article
  10. 10

    Structure factorielle et qualités psychométriques de la version française de l’inventaire de comportements des adultes (Adult Behavior Checklist) d’Achenbach et Rescorla by Petot, J.-M., Vrignaud, P., Zebdi, R., Camart, N.

    Published in Psychologie française (01-06-2014)
    “…Il est souvent utile aux cliniciens de recueillir sur leurs patients des informations fournies par des proches, surtout lorsque les patients eux-mêmes ne sont…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Translational research and Cancer Plan by Vassal, G, Borella, L, Pierre, A, Pamphile, R, Bourrie, B, Meflah, K, Amalric, F, Pauporte, I, Caillot, J-L, Formstecher, P, Demers, B, Dumontet, C, Grégoire, M, Lethiec, F, Boue, A-M, Tonelli, D, Pilsudski, R, Van Hijfte, L, Cailliot, C, Vrignaud, P, Merlin, J-L, Oudet, P, Arnoux, P-Y, Lassale, C

    Published in Bulletin du cancer (01-12-2007)
    “…The French Cancer Plan 2003-2007 has made translational research central to its research programme, to ensure the care-research continuum and the quickest…”
    Get more information
    Journal Article
  13. 13
  14. 14

    Santé psychique et fardeau des aidants familiaux de personnes atteintes de la maladie d’Alzheimer ou de troubles apparentés by Kerhervé, H., Gay, M.-C., Vrignaud, P.

    Published in Annales médico psychologiques (01-05-2008)
    “…Les études nord-américaines sur la maladie d’Alzheimer mettent en évidence le fardeau que portent les proches du malade qui ont un rôle d’aidant familial et…”
    Get full text
    Journal Article
  15. 15

    Synthesis and Structure-Activity Relationships of New Antitumor Taxoids. Effects of Cyclohexyl Substitution at the C-3' and/or C-2 of Taxotere (Docetaxel) by Ojima, Iwao, Duclos, Olivier, Zucco, Martine, Bissery, Marie-Christine, Combeau, C, Vrignaud, P, Riou, J. F, Lavelle, Francois

    Published in Journal of medicinal chemistry (01-08-1994)
    “…Synthesis and cytotoxicity of the new analogs (11-13) of docetaxel possessing cyclohexyl groups instead of phenyl groups at the C-3' and/or C-2 benzoate…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Preclinical profile of cabazitaxel by Vrignaud, Patricia, Semiond, Dorothée, Benning, Veronique, Beys, Eric, Bouchard, Hervé, Gupta, Sunil

    Published in Drug design, development and therapy (01-01-2014)
    “…First-generation taxanes have changed the treatment paradigm for a wide variety of cancers, but innate or acquired resistance frequently limits their use…”
    Get full text
    Journal Article
  18. 18

    Cross-cultural validation of a French version of the Emotional Processing Scale (EPS-25) by Gay, M.-C., Baker, R., Vrignaud, P., Thomas, P., Heinzlef, O., Haag, P., Banovic, I., Thomas, S.

    “…The Emotional Processing Scale (EPS) is a self-report questionnaire consisting of 25 items designed to identify emotional processing styles and impairments…”
    Get full text
    Journal Article
  19. 19

    Assessment of the experimental model of transplanted C6 glioblastoma in Wistar rats by SAN-GALLI, F, VRIGNAUD, P, ROBERT, J, COINDRE, J. M, COHADON, F

    Published in Journal of neuro-oncology (01-09-1989)
    “…Establishing in vivo glioblastoma models from cell lines requires a very strict methodology, in order to obtain reproducible tumors presenting all the…”
    Get full text
    Journal Article
  20. 20